Manchester Capital Management’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-34,265
Closed -$5.57K 1076
2023
Q4
$5.57K Hold
34,265
﹤0.01% 686
2023
Q3
$15.2K Sell
34,265
-34,265
-50% -$15.6K ﹤0.01% 557
2023
Q2
$25.3K Buy
68,530
+34,265
+100% +$29.2K ﹤0.01% 478
2023
Q1
$62.4K Hold
34,265
0.01% 407
2022
Q4
$70.9K Hold
34,265
0.01% 349
2022
Q3
$103K Hold
34,265
0.02% 284
2022
Q2
$110K Sell
34,265
-37,600
-52% -$204K 0.02% 283
2022
Q1
$464K Buy
+71,865
New +$650K 0.07% 171

Other funds holding HLTH

Manchester Capital Management's HLTH Position: Q1 2024 in Review

Manchester Capital Management sold out of Cue Health Inc. Common Stock (HLTH) in Q1 2024, closing a stake of 34,265 shares — an estimated $5.57K sold.

Manchester Capital Management first reported a position in HLTH in Q1 2022 and held it in 8 quarters. The position peaked at $464K in Q1 2022. 57 funds tracked by Wall St. Rank hold HLTH as of Q1 2024.

  • Manchester Capital Management reported no remaining Cue Health Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Manchester Capital Management sold 34,265 Cue Health Inc. Common Stock shares in Q1 2024, an estimated $5.57K.
  • Manchester Capital Management first reported a position in Cue Health Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Manchester Capital Management's Cue Health Inc. Common Stock position peaked at $464K in Q1 2022.
  • 57 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q1 2024.

Based on Manchester Capital Management's 13F filing for Q1 2024, filed 6 May 2024.